RITUXIMAB Side Effects

7023678-5 | Dyspnoea
on Sep 29, 2010 Male patient from UNITED STATES , 75 years of age, weighting 123.5 lb, was treated with Rituximab (View Usage). Patient experienced the following unwanted or unexpected effects: dyspnoea. Rituximab dosage: 619 Mg Once Iv.

7023512-3 | Pyrexia, Rash
Patient was taking Rituximab (View Usage). Patient had the following side effects: pyrexia, rash (What is rash?) on Sep 29, 2010 from UNITED STATES Additional patient health information: Male patient , 53 years of age, weighting 235.9 lb, . Rituximab dosage: 870 Mg Once Iv. Patient was hospitalized.

7023499-3 | Alopecia, Dysgeusia, Hair Texture Abnormal, Headache, Hot Flush, Skin Lesion, Syncope
Adverse event was reported on Sep 20, 2010 by a Female patient taking Rituximab (View Usage) (Dosage: 1000 Mg, Unk) was diagnosed with systemic lupus erythematosus and. Location: UNITED KINGDOM , weighting 149.9 lb, After Rituximab was administered, patient had the following side effects: alopecia, dysgeusia, hair texture abnormal, headache (What is headache?), hot flush, skin lesion, syncope. During the same period patient was treated with TYLENOL (750 Mg, Unk) (View Tylenol Review and Tylenol Label ).

7023488-9 | Injury, Splenic Rupture
on Sep 21, 2010 Male patient from UNITED KINGDOM , 47 years of age, weighting 154.3 lb, was diagnosed with chronic lymphocytic leukaemia and was treated with Rituximab (View Usage). Patient experienced the following unwanted or unexpected effects: injury, splenic rupture. Rituximab dosage: 500 Mg, Unk. Patient was hospitalized.


7023425-7 | Cardiac Disorder, Tumour Lysis Syndrome
on Sep 23, 2010 Male patient from UNITED KINGDOM , 93 years of age, was diagnosed with chronic lymphocytic leukaemia and was treated with Rituximab (View Usage). Patient had the following side effects: cardiac disorder, tumour lysis syndrome. Rituximab dosage: Unk. During the same period patient was treated with FLUDARABINE (Unk) (View Fludarabine Review and Fludarabine Label ), CYCLOPHOSPHAMIDE (Unk) (View Cyclophosphamide Review and Cyclophosphamide Label ).

7023210-6 | Influenza Like Illness, Pyrexia
Patient was taking Rituximab (View Usage). After Rituximab was administered, patient had the following side effects: influenza like illness, pyrexia on Sep 19, 2010 from UNITED KINGDOM Additional patient health information: Male patient , 81 years of age, weighting 165.3 lb, was diagnosed with chronic lymphocytic leukaemia and. Rituximab dosage: 375 Mg, Unk. Patient was hospitalized.

7022561-9 | Pyrexia
Adverse event was reported on Sep 17, 2010 by a Male patient taking Rituximab (View Usage) (Dosage: 500 Mg, Unk) was diagnosed with chronic lymphocytic leukaemia and. Location: UNITED KINGDOM , 81 years of age, weighting 200.6 lb, Patient experienced the following unwanted or unexpected effects: pyrexia. During the same period patient was treated with BENDAMUSTINE (90 Mg, Unk) (View Bendamustine Review and Bendamustine Label ). Patient was hospitalized.

7022542-5 | Erysipelas, Hypersensitivity, Limb Injury, Nephrocalcinosis, Urethral Disorder, Varicose Vein
on Sep 16, 2010 Female patient from UNITED KINGDOM , weighting 172.0 lb, was diagnosed with rheumatoid arthritis (What is rheumatoid arthritis?) and was treated with Rituximab (View Usage). Patient had the following side effects: erysipelas, hypersensitivity, limb injury, nephrocalcinosis, urethral disorder, varicose vein (What is varicose vein?). Rituximab dosage: 1000 Mg, Unk. During the same period patient was treated with METICORTEN (Unk) (View Meticorten Review and Meticorten Label ), AMITRIPTYLINE HCL (25 Mg, Unk) (View Amitriptyline Hcl Review and Amitriptyline Hcl Label ), PREDNISONE (10 Mg, Unk) (View Prednisone Review and Prednisone Label ), DIOSMIN (450 Mg, Unk) (View Diosmin Review and Diosmin Label ). Patient was hospitalized.

7021452-7 | Acute Hepatic Failure, Hepatitis B, Renal Failure
on Sep 15, 2010 Male patient from UNITED KINGDOM , weighting 180.8 lb, was diagnosed with lymphoplasmacytoid lymphoma/immunocytoma and was treated with Rituximab (View Usage). After Rituximab was administered, patient had the following side effects: acute hepatic failure, hepatitis b (What is hepatitis b?), renal failure. Rituximab dosage: 750 Mg, Unk. During the same period patient was treated with BENDAMUSTINE (180 Mg, Unk) (View Bendamustine Review and Bendamustine Label ). Patient was hospitalized.

7021404-7 | Pain In Extremity, Somnolence, Systemic Lupus Erythematosus
Patient was taking Rituximab (View Usage). Patient experienced the following unwanted or unexpected effects: pain in extremity, somnolence, systemic lupus erythematosus on Sep 17, 2010 from UNITED KINGDOM Additional patient health information: Female patient , weighting 143.3 lb, was diagnosed with rheumatoid arthritis (What is rheumatoid arthritis?), pain in extremity, prophylaxis and. Rituximab dosage: 1000 Mg, Q15d. During the same period patient was treated with TRAMADOL HCL (Unk) (View Tramadol Hcl Review and Tramadol Hcl Label ), NOVALGINA (Unk) (View Novalgina Review and Novalgina Label ), METICORTEN (20 Mg, Unk) (View Meticorten Review and Meticorten Label ), OMEPRAZOLE (40 Mg, Unk) (View Omeprazole Review and Omeprazole Label ), PROPRANOLOL (Unk Mg, Unk) (View Propranolol Review and Propranolol Label ), TICLID (250 Mg, Unk) (View Ticlid Review and Ticlid Label ), METFORMIN HYDROCHLORIDE (Unk) (View Metformin Hydrochloride Review and Metformin Hydrochloride Label ), AMITRIPTYLINE (25 Mg, Unk) (View Amitriptyline Review and Amitriptyline Label ). Patient was hospitalized.

7021236-X | Arthralgia, Dyspepsia, Ear Pain, Finger Deformity, Gait Disturbance, Hypertension, Ill-defined Disorder, Oedema Peripheral
Adverse event was reported on Sep 15, 2010 by a Female patient taking Rituximab (View Usage) (Dosage: 1000 Mg, Q15d) was diagnosed with rheumatoid arthritis (What is rheumatoid arthritis?), scleroderma (What is scleroderma?) and. Location: UNITED KINGDOM , weighting 141.1 lb, Patient had the following side effects: arthralgia, dyspepsia, ear pain, finger deformity, gait disturbance, hypertension, ill-defined disorder, oedema peripheral. During the same period patient was treated with CHLOROQUINE PHOSPHATE (Unk) (View Chloroquine Phosphate Review and Chloroquine Phosphate Label ), DILTIAZEM (2.5 Mg, Unk) (View Diltiazem Review and Diltiazem Label ), OMEPRAZOLE (Unk) (View Omeprazole Review and Omeprazole Label ), BROMOPRIDE (Unk) (View Bromopride Review and Bromopride Label ).

7021210-3 | Cerebral Toxoplasmosis, Progressive Multifocal Leukoencephalopathy
on Sep 15, 2010 Male patient from UNITED KINGDOM , 63 years of age, was diagnosed with chronic lymphocytic leukaemia and was treated with Rituximab (View Usage). After Rituximab was administered, patient had the following side effects: cerebral toxoplasmosis, progressive multifocal leukoencephalopathy. Rituximab dosage: Unk. During the same period patient was treated with FLUDARABINE (Unk) (View Fludarabine Review and Fludarabine Label ), CYCLOPHOSPHAMIDE (Unk) (View Cyclophosphamide Review and Cyclophosphamide Label ).

7020769-X | Alopecia, Anaemia, Laryngeal Oedema, Weight Decreased
on Sep 14, 2010 Female patient from UNITED KINGDOM , weighting 114.6 lb, was diagnosed with rheumatoid arthritis (What is rheumatoid arthritis?) and was treated with Rituximab (View Usage). Patient experienced the following unwanted or unexpected effects: alopecia, anaemia, laryngeal oedema, weight decreased. Rituximab dosage: Unk. During the same period patient was treated with BIOFENAC (Unk) (View Biofenac Review and Biofenac Label ), EUTHYROX (50 Mg, Unk) (View Euthyrox Review and Euthyrox Label ), PANTOPRAZOLE SODIUM (40 Mg, Unk) (View Pantoprazole Sodium Review and Pantoprazole Sodium Label ), METICORTEN (Unk) (View Meticorten Review and Meticorten Label ), CALCIUM (Unk) (View Calcium Review and Calcium Label ), TYLENOL (2 Unit, Unk) (View Tylenol Review and Tylenol Label ).

7019273-4 | Bone Marrow Failure, Fungal Sepsis, Gastrointestinal Hypomotility
Patient was taking Rituximab (View Usage). Patient had the following side effects: bone marrow failure, fungal sepsis, gastrointestinal hypomotility on Sep 12, 2010 from UNITED KINGDOM Additional patient health information: Male patient , child 11 years of age, was diagnosed with b-cell lymphoma and. Rituximab dosage: 375 Mg/m2, Unk. During the same period patient was treated with CYCLOPHOSPHAMIDE (Unk Unk, Q28d) (View Cyclophosphamide Review and Cyclophosphamide Label ), DOXORUBICIN HCL (Unk) (View Doxorubicin Hcl Review and Doxorubicin Hcl Label ), VINCRISTINE (Unk) (View Vincristine Review and Vincristine Label ), PREDNISONE (Unk) (View Prednisone Review and Prednisone Label ), PARACETAMOL (Prior To Rituximab) (View Paracetamol Review and Paracetamol Label ), DIPHENHYDRAMINE (Prior To Rituximab, Slow Infusion) (View Diphenhydramine Review and Diphenhydramine Label ).

7018925-X | Arthropathy
Adverse event was reported on Sep 15, 2010 by a Female patient taking Rituximab (View Usage) (Dosage: 1000 Mg/kg, Unk) was diagnosed with rheumatoid arthritis (What is rheumatoid arthritis?) and. Location: UNITED KINGDOM , 47 years of age, After Rituximab was administered, patient had the following side effects: arthropathy. During the same period patient was treated with ENBREL (50 Mg, 1/week) (View Enbrel Review and Enbrel Label ), CHLOROQUINE PHOSPHATE (Unk) (View Chloroquine Phosphate Review and Chloroquine Phosphate Label ), MELOXICAM (15 Mg, Prn) (View Meloxicam Review and Meloxicam Label ), CALCORT (6 Mg, Qod) (View Calcort Review and Calcort Label ).

7018923-6 | Diarrhoea, Vomiting
on Sep 13, 2010 Female patient from UNITED KINGDOM , 67 years of age, was diagnosed with rheumatoid arthritis (What is rheumatoid arthritis?), pain (What is pain?), hypersensitivity, inflammation, asthma (What is asthma?) and was treated with Rituximab (View Usage). Patient experienced the following unwanted or unexpected effects: diarrhoea, vomiting. Rituximab dosage: 1000 Mg, Unk. During the same period patient was treated with CO DYDRAMOL (Unk) (View Co-dydramol Review and Co-dydramol Label ), FEXOFENADINE HCL (120 Mg, Qam) (View Fexofenadine Hcl Review and Fexofenadine Hcl Label ), IBUPROFEN (800 Mg, Bid) (View Ibuprofen Review and Ibuprofen Label ), LEFLUNOMIDE (20 Mg, Qam) (View Leflunomide Review and Leflunomide Label ), NASACORT (55 A?g, Unk) (View Nasacort Review and Nasacort Label ), OMEPRAZOLE (40 Mg, Qam) (View Omeprazole Review and Omeprazole Label ), VENTOLIN (2 Df, Unk) (View Ventolin Review and Ventolin Label ). Patient was hospitalized.

7018912-1 | Joint Destruction
on Sep 15, 2010 Female patient from UNITED KINGDOM , weighting 132.3 lb, was diagnosed with rheumatoid arthritis (What is rheumatoid arthritis?) and was treated with Rituximab (View Usage). Patient had the following side effects: joint destruction. Rituximab dosage: Unk. During the same period patient was treated with TYLENOL (Unk) (View Tylenol Review and Tylenol Label ).

7018703-1 | Anaemia, Blood Immunoglobulin M Increased, Condition Aggravated, Deafness, Depressed Level Of Consciousness, Hyperviscosity Syndrome
Patient was taking Rituximab (View Usage). After Rituximab was administered, patient had the following side effects: anaemia, blood immunoglobulin m increased, condition aggravated, deafness, depressed level of consciousness, hyperviscosity syndrome on Sep 13, 2010 from UNITED KINGDOM Additional patient health information: Male patient , 75 years of age, was diagnosed with chronic lymphocytic leukaemia and. Rituximab dosage: Unk. During the same period patient was treated with METHYLPREDNISOLONE (Unk) (View Methylprednisolone Review and Methylprednisolone Label ). Patient was hospitalized.

7016897-5 | Blood Creatinine Abnormal, Blood Urea Abnormal, Hypertension, Palpitations, Tongue Dry, White Blood Cell Count Abnormal
Adverse event was reported on Sep 13, 2010 by a Female patient taking Rituximab (View Usage) (Dosage: Unk) was diagnosed with systemic lupus erythematosus and. Location: UNITED KINGDOM , weighting 138.9 lb, Patient experienced the following unwanted or unexpected effects: blood creatinine abnormal, blood urea abnormal, hypertension, palpitations, tongue dry, white blood cell count abnormal. During the same period patient was treated with PREDNISONE (20 Mg, Unk) (View Prednisone Review and Prednisone Label ), HYDROXYCHLOROQUINE SULFATE (400 Mg, Unk) (View Hydroxychloroquine Sulfate Review and Hydroxychloroquine Sulfate Label ), PRESS PLUS (Unk) (View Press Plus Review and Press Plus Label ), ATENOLOL (25 Mg, Unk) (View Atenolol Review and Atenolol Label ), CAPTOPRIL (25 Mg, Unk) (View Captopril Review and Captopril Label ), OMEPRAZOLE (20 Mg, Unk) (View Omeprazole Review and Omeprazole Label ).

7016884-7 | Bone Marrow Failure, Fungal Sepsis
on Sep 12, 2010 Male patient from UNITED KINGDOM , child 4 years of age, was diagnosed with b-cell lymphoma and was treated with Rituximab (View Usage). Patient had the following side effects: bone marrow failure, fungal sepsis. Rituximab dosage: 375 Mg/m2, Unk. During the same period patient was treated with CYCLOPHOSPHAMIDE (Unk Unk, Q28d) (View Cyclophosphamide Review and Cyclophosphamide Label ), DOXORUBICIN HCL (Unk) (View Doxorubicin Hcl Review and Doxorubicin Hcl Label ), PREDNISONE (Unk) (View Prednisone Review and Prednisone Label ), VINCRISTINE (Unk) (View Vincristine Review and Vincristine Label ), ACETAMINOPHEN (15 Mg/kg, Unk) (View Acetaminophen Review and Acetaminophen Label ), DIPHENHYDRAMINE HCL (Unk) (View Diphenhydramine Hcl Review and Diphenhydramine Hcl Label ).

7016883-5 | Dyspnoea, Mouth Ulceration, Swollen Tongue
on Sep 13, 2010 Female patient from UNITED KINGDOM , 70 years of age, was diagnosed with rheumatoid arthritis (What is rheumatoid arthritis?), hypertension, pain (What is pain?) and was treated with Rituximab (View Usage). After Rituximab was administered, patient had the following side effects: dyspnoea, mouth ulceration, swollen tongue. Rituximab dosage: 1000 Mg, Unk. During the same period patient was treated with LISINOPRIL (2.5 Mg, Unk) (View Lisinopril Review and Lisinopril Label ), AMITRIPTYLINE HCL (25 Mg, Unk) (View Amitriptyline Hcl Review and Amitriptyline Hcl Label ), MEBEVERINE (135 Mg, Tid) (View Mebeverine Review and Mebeverine Label ), SULPHASALAZINE (1 G, Bid) (View Sulphasalazine Review and Sulphasalazine Label ), TRAMADOL (1 Df, Qid) (View Tramadol Review and Tramadol Label ).

7016882-3 | Anaphylactic Reaction, Asthma, Dyspnoea, Hypotension
Patient was taking Rituximab (View Usage). Patient experienced the following unwanted or unexpected effects: anaphylactic reaction, asthma (What is asthma?), dyspnoea, hypotension on Sep 14, 2010 from GERMANY Additional patient health information: Female patient , weighting 174.2 lb, was diagnosed with rheumatoid arthritis (What is rheumatoid arthritis?), diabetes mellitus and. Rituximab dosage: 1000 Mg, Unk. During the same period patient was treated with INSULIN (Unk) (View Insulin Review and Insulin Label ), PREDNISOLON (Unk) (View Prednisolon Review and Prednisolon Label ), DIMETINDENE (5 Mg, Unk) (View Dimetindene Review and Dimetindene Label ), PREDNISOLONE SODIUM SUCCINATE INJ (100 Mg, Unk) (View Prednisolone Sodium Succinate Inj Review and Prednisolone Sodium Succinate Inj Label ). Patient was hospitalized.

7016858-6 | Facial Pain, Hypersensitivity, Infection, Memory Impairment, Nodule, Swelling Face
Adverse event was reported on Sep 13, 2010 by a Female patient taking Rituximab (View Usage) (Dosage: 1000 Mg, Q14d) was diagnosed with rheumatoid arthritis (What is rheumatoid arthritis?) and. Location: UNITED KINGDOM , weighting 176.4 lb, Patient had the following side effects: facial pain, hypersensitivity, infection (What is infection?), memory impairment, nodule, swelling face. During the same period patient was treated with ENBREL (Unk) (View Enbrel Review and Enbrel Label ), METHOTREXATE (Unk) (View Methotrexate Review and Methotrexate Label ), BIOFENAC (Unk) (View Biofenac Review and Biofenac Label ), PRELONE (Unk) (View Prelone Review and Prelone Label ), ACETAMINOPHEN (Unk) (View Acetaminophen Review and Acetaminophen Label ). Patient was hospitalized.

7016850-1 | Acquired Epidermolysis Bullosa, Blood Disorder, Bone Marrow Failure, Fungal Infection, Ill-defined Disorder, Meningeal Disorder, Oral Fungal Infection
on Sep 12, 2010 Female patient from UNITED KINGDOM , child 7 years of age, was diagnosed with diffuse large b-cell lymphoma and was treated with Rituximab (View Usage). After Rituximab was administered, patient had the following side effects: acquired epidermolysis bullosa, blood disorder, bone marrow failure, fungal infection (What is fungal infection?), ill-defined disorder, meningeal disorder, oral fungal infection. Rituximab dosage: 375 Mg/m2, Unk. During the same period patient was treated with CYCLOPHOSPHAMIDE (Unk Unk, Q28d) (View Cyclophosphamide Review and Cyclophosphamide Label ), DOXORUBICIN HCL (Unk) (View Doxorubicin Hcl Review and Doxorubicin Hcl Label ), VINCRISTINE (Unk) (View Vincristine Review and Vincristine Label ), PREDNISONE (Unk) (View Prednisone Review and Prednisone Label ), ACETAMINOPHEN (15 Mg/kg, Unk) (View Acetaminophen Review and Acetaminophen Label ), DIPHENHYDRAMINE HCL (Unk) (View Diphenhydramine Hcl Review and Diphenhydramine Hcl Label ).

7016843-4 | Bone Marrow Failure, Diffuse Large B-cell Lymphoma, Diffuse Large B-cell Lymphoma Recurrent, Superinfection Fungal
on Sep 12, 2010 Male patient from UNITED KINGDOM , 15 years of age, was diagnosed with b-cell lymphoma and was treated with Rituximab (View Usage). Patient experienced the following unwanted or unexpected effects: bone marrow failure, diffuse large b-cell lymphoma, diffuse large b-cell lymphoma recurrent, superinfection fungal. Rituximab dosage: 375 Mg/m2, Unk. During the same period patient was treated with CYCLOPHOSPHAMIDE (Unk Unk, Q28d) (View Cyclophosphamide Review and Cyclophosphamide Label ), DOXORUBICIN HCL (Unk) (View Doxorubicin Hcl Review and Doxorubicin Hcl Label ), PREDNISONE (Unk) (View Prednisone Review and Prednisone Label ), VINCRISTINE (Unk) (View Vincristine Review and Vincristine Label ), ACETAMINOPHEN (15 Mg/kg, Unk) (View Acetaminophen Review and Acetaminophen Label ), DIPHENHYDRAMINE HCL (Unk) (View Diphenhydramine Hcl Review and Diphenhydramine Hcl Label ).

7016842-2 | Blood Creatinine Increased, Cytomegalovirus Viraemia, Diarrhoea, Hypogammaglobulinaemia, Pancytopenia, Pneumonia, Sepsis
Patient was taking Rituximab (View Usage). Patient had the following side effects: blood creatinine increased, cytomegalovirus viraemia, diarrhoea, hypogammaglobulinaemia, pancytopenia, pneumonia (What is pneumonia?), sepsis (What is sepsis?) on Sep 13, 2010 from UNITED KINGDOM Additional patient health information: Male patient , 43 years of age, was diagnosed with transplant rejection, prophylaxis against transplant rejection and. Rituximab dosage: 375 Mg/m2, Unk. During the same period patient was treated with DACLIZUMAB (Unk) (View Daclizumab Review and Daclizumab Label ), MYCOPHENOLATE MOFETIL (Unk) (View Mycophenolate Mofetil Review and Mycophenolate Mofetil Label ), TACROLIMUS (Unk) (View Tacrolimus Review and Tacrolimus Label ), PREDNISOLONE (Unk) (View Prednisolone Review and Prednisolone Label ). Patient was hospitalized.

7016807-0 | Breast Cancer, Breast Discharge
Adverse event was reported on Sep 15, 2010 by a Female patient taking Rituximab (View Usage) (Dosage: 1000 Mg, Unk) was diagnosed with rheumatoid arthritis (What is rheumatoid arthritis?) and. Location: UNITED KINGDOM , 73 years of age, After Rituximab was administered, patient had the following side effects: breast cancer (What is breast cancer?), breast discharge. During the same period patient was treated with ALENDRONATE SODIUM (Unk) (View Alendronate Sodium Review and Alendronate Sodium Label ), ASPIRIN (Unk) (View Aspirin Review and Aspirin Label ), FOLIC ACID (Unk) (View Folic Acid Review and Folic Acid Label ), METHOTREXATE (Unk) (View Methotrexate Review and Methotrexate Label ).

7016779-9 | Upper Gastrointestinal Haemorrhage
on Sep 14, 2010 Male patient from UNITED KINGDOM , weighting 141.1 lb, was diagnosed with diffuse large b-cell lymphoma and was treated with Rituximab (View Usage). Patient experienced the following unwanted or unexpected effects: upper gastrointestinal haemorrhage. Rituximab dosage: 683 Mg, Unk. During the same period patient was treated with CYCLOPHOSPHAMIDE (Unk) (View Cyclophosphamide Review and Cyclophosphamide Label ), DOXORUBICIN HCL (Unk) (View Doxorubicin Hcl Review and Doxorubicin Hcl Label ), VINCRISTINE (Unk) (View Vincristine Review and Vincristine Label ). Patient was hospitalized.

7016775-1 | Arterial Occlusive Disease, Pain, Renal Failure
on Sep 13, 2010 Female patient from UNITED KINGDOM , weighting 90.39 lb, was diagnosed with rheumatoid arthritis (What is rheumatoid arthritis?) and was treated with Rituximab (View Usage). Patient had the following side effects: arterial occlusive disease, pain (What is pain?), renal failure. Rituximab dosage: Unk. During the same period patient was treated with AMLODIPINE (10 Mg, Unk) (View Amlodipine Review and Amlodipine Label ), LONITEN (10 Mg, Unk) (View Loniten Review and Loniten Label ), CAPTOPRIL (50 Mg, Unk) (View Captopril Review and Captopril Label ), ATENOLOL (50 Mg, Unk) (View Atenolol Review and Atenolol Label ), OMEPRAZOLE (20 Mg, Unk) (View Omeprazole Review and Omeprazole Label ), FOLIC ACID (5 Mg, Unk) (View Folic Acid Review and Folic Acid Label ). Patient was hospitalized.

7016771-4 | Abdominal Pain Upper, Chest Pain, Dehydration, Electrolyte Imbalance, Gastrointestinal Infection, Heart Rate Increased, Movement Disorder, Pericardial Effusion
Patient was taking Rituximab (View Usage). After Rituximab was administered, patient had the following side effects: abdominal pain upper, chest pain (What is chest pain?), dehydration, electrolyte imbalance, gastrointestinal infection, heart rate increased, movement disorder (What is movement disorder?), pericardial effusion on Sep 14, 2010 from UNITED KINGDOM Additional patient health information: Female patient , weighting 149.9 lb, was diagnosed with rheumatoid arthritis (What is rheumatoid arthritis?), arthralgia and. Rituximab dosage: 1000 Mg, Q15d. During the same period patient was treated with PREDNISONE (0.5 Unk, Unk) (View Prednisone Review and Prednisone Label ), ADALAT (Unk) (View Adalat Review and Adalat Label ), ACETYLSALICYLIC ACID (Unk) (View Acetylsalicylic Acid Review and Acetylsalicylic Acid Label ), DIPYRONE (Unk) (View Dipyrone Review and Dipyrone Label ). Patient was hospitalized.

7016770-2 | Abasia, Arthropathy, Bone Pain, Breast Enlargement, Weight Increased
Adverse event was reported on Sep 13, 2010 by a Female patient taking Rituximab (View Usage) (Dosage: Unk) was diagnosed with rheumatoid arthritis (What is rheumatoid arthritis?), systemic lupus erythematosus and. Location: UNITED KINGDOM , weighting 132.3 lb, Patient experienced the following unwanted or unexpected effects: abasia, arthropathy, bone pain, breast enlargement, weight increased. During the same period patient was treated with METHOTREXATE (2.5 Mg, Unk) (View Methotrexate Review and Methotrexate Label ), FOLIC ACID (5 Mg, Unk) (View Folic Acid Review and Folic Acid Label ), FLUOXETINE (20 Mg, Unk) (View Fluoxetine Review and Fluoxetine Label ), RIVOTRIL (2.5 Mg, Unk) (View Rivotril Review and Rivotril Label ), FRONTAL (2 Mg, Unk) (View Frontal Review and Frontal Label ), CAPTOPIRIL (50 Mg, Unk) (View Captopiril Review and Captopiril Label ), HYDROCHLOROTHIAZIDE (50 Mg, Unk) (View Hydrochlorothiazide Review and Hydrochlorothiazide Label ). Patient was hospitalized.

7015560-4 | Aphthous Stomatitis, Asthenia, Bacterial Infection, Cardio-respiratory Arrest, Cystitis, Eating Disorder, Erysipelas, Hypertension, Immunodeficiency
on Sep 15, 2010 Female patient from BRAZIL , weighting 149.9 lb, was diagnosed with rheumatoid arthritis (What is rheumatoid arthritis?) and was treated with Rituximab (View Usage). Patient had the following side effects: aphthous stomatitis, asthenia, bacterial infection (What is bacterial infection?), cardio-respiratory arrest, cystitis, eating disorder (What is eating disorder?), erysipelas, hypertension, immunodeficiency. Rituximab dosage: 1000 Mg, Unk. During the same period patient was treated with METHOTREXATE (25 Mg, Unk) (View Methotrexate Review and Methotrexate Label ), ENALAPRIL (20 Mg, Unk) (View Enalapril Review and Enalapril Label ), HYDROCHLOROTHIAZIDE (5 Mg, Unk) (View Hydrochlorothiazide Review and Hydrochlorothiazide Label ), RANITIDINE (Unk) (View Ranitidine Review and Ranitidine Label ), OMEPRAZOLE (Unk) (View Omeprazole Review and Omeprazole Label ), CHOLECALCIFEROL (Unk) (View Cholecalciferol Review and Cholecalciferol Label ), TYLEX (Unk) (View Tylex Review and Tylex Label ), INFLIXIMAB (View Infliximab Review and Infliximab Label ). Patient was hospitalized.

7013907-6 | Chest Pain
on Sep 16, 2010 Male patient from UNITED STATES , weighting 174.2 lb, was diagnosed with rheumatoid arthritis (What is rheumatoid arthritis?) and was treated with Rituximab (View Usage). After Rituximab was administered, patient had the following side effects: chest pain (What is chest pain?). Rituximab dosage: 1000 Mg, D1+15/q6m. Patient was hospitalized.

7013848-4 | Atrial Flutter, Subdural Haematoma
Patient was taking Rituximab (View Usage). Patient experienced the following unwanted or unexpected effects: atrial flutter, subdural haematoma on Sep 10, 2010 from UNITED KINGDOM Additional patient health information: Male patient , weighting 189.6 lb, was diagnosed with non-hodgkin's lymphoma and. Rituximab dosage: 970 Mg, Unk. During the same period patient was treated with CYCLOPHOSPHAMIDE (1455 Mg, Unk) (View Cyclophosphamide Review and Cyclophosphamide Label ), DOXORUBICIN HCL (97 Mg, Unk) (View Doxorubicin Hcl Review and Doxorubicin Hcl Label ), VINCRISTINE (2 Mg, Unk) (View Vincristine Review and Vincristine Label ), PEGFILGRASTIM (Unk) (View Pegfilgrastim Review and Pegfilgrastim Label ), RAMIPRIL (Unk) (View Ramipril Review and Ramipril Label ), SIMVASTATIN (Unk) (View Simvastatin Review and Simvastatin Label ), METOPROLOL TARTRATE (Unk) (View Metoprolol Tartrate Review and Metoprolol Tartrate Label ). Patient was hospitalized.

7013801-0 | Bronchopneumonia, Deep Vein Thrombosis, Encephalitis, Pneumonia Primary Atypical, Pulmonary Embolism
Adverse event was reported on Sep 09, 2010 by a Female patient taking Rituximab (View Usage) (Dosage: 660 Mg, 1/month) was diagnosed with b-cell lymphoma and. Location: UNITED KINGDOM , weighting 158.7 lb, Patient had the following side effects: bronchopneumonia, deep vein thrombosis (What is deep vein thrombosis?), encephalitis (What is encephalitis?), pneumonia primary atypical, pulmonary embolism (What is pulmonary embolism?). During the same period patient was treated with MITOXANTRON (14 Mg, 1/month) (View Mitoxantron Review and Mitoxantron Label ), CHLORAMBUCIL (15.9 Mg, 1/month) (View Chlorambucil Review and Chlorambucil Label ), PREDNISOLONE (40 Mg, 1/month) (View Prednisolone Review and Prednisolone Label ), RAMIPRIL (Unk) (View Ramipril Review and Ramipril Label ), PROTAPHANE (Unk) (View Protaphane Review and Protaphane Label ), SIOFOR (2 Df, Qd) (View Siofor Review and Siofor Label ). Patient was hospitalized.

7013505-4 | Lung Infiltration
on Sep 15, 2010 Male patient from UNITED KINGDOM , weighting 183.0 lb, was diagnosed with diffuse large b-cell lymphoma, prophylaxis and was treated with Rituximab (View Usage). After Rituximab was administered, patient had the following side effects: lung infiltration. Rituximab dosage: 750 Mg, Unk. During the same period patient was treated with PREDNISONE TAB (100 Mg, Unk) (View Prednisone Tab Review and Prednisone Tab Label ), CYCLOPHOSPHAMIDE (1500 Mg, Unk) (View Cyclophosphamide Review and Cyclophosphamide Label ), DOXORUBICIN HCL (100 Mg, Unk) (View Doxorubicin Hcl Review and Doxorubicin Hcl Label ), VINCRISTINE (1 Mg, Unk) (View Vincristine Review and Vincristine Label ), NEUPOGEN (480 Mg, Unk) (View Neupogen Review and Neupogen Label ), ACETAMINOPHEN (3000 Mg, Unk) (View Acetaminophen Review and Acetaminophen Label ), VALACYCLOVIR HYDROCHLORIDE (1000 Mg, Unk) (View Valacyclovir Hydrochloride Review and Valacyclovir Hydrochloride Label ). Patient was hospitalized.

7013493-0 | Abdominal Pain, Arthralgia, Back Pain, Bone Pain, Diarrhoea, Dry Mouth, Fall, Fatigue, Formication
on Sep 13, 2010 Female patient from UNITED KINGDOM , weighting 189.6 lb, was diagnosed with rheumatoid arthritis (What is rheumatoid arthritis?), pain (What is pain?) and was treated with Rituximab (View Usage). Patient experienced the following unwanted or unexpected effects: abdominal pain (What is abdominal pain?), arthralgia, back pain (What is back pain?), bone pain, diarrhoea, dry mouth, fall (What is fall?), fatigue, formication. Rituximab dosage: 1000 Mg, Q15d. During the same period patient was treated with PREDNISONE TAB (5 Mg, Unk) (View Prednisone Tab Review and Prednisone Tab Label ), PRESSOTEC (Unk) (View Pressotec Review and Pressotec Label ), DICLOFENAC (Unk) (View Diclofenac Review and Diclofenac Label ), METHOTREXATE (2.5 Mg, Unk) (View Methotrexate Review and Methotrexate Label ), DORFLEX (Unk) (View Dorflex Review and Dorflex Label ), NOVALGIN (Unk) (View Novalgin Review and Novalgin Label ), RIVOTRIL (2 Mg, Unk) (View Rivotril Review and Rivotril Label ).

7013474-7 | Dyspnoea, Fall, Pulmonary Oedema, Rib Fracture, Spinal Fracture
Patient was taking Rituximab (View Usage). Patient had the following side effects: dyspnoea, fall (What is fall?), pulmonary oedema, rib fracture, spinal fracture on Sep 13, 2010 from UNITED KINGDOM Additional patient health information: Male patient , weighting 172.0 lb, was diagnosed with chronic lymphocytic leukaemia and. Rituximab dosage: 700 Mg, Q28d. During the same period patient was treated with HYDROMORPHONE HCL (Unk) (View Hydromorphone Hcl Review and Hydromorphone Hcl Label ), ALLOPURINOL (Unk) (View Allopurinol Review and Allopurinol Label ). Patient was hospitalized.

7013179-2 | Febrile Neutropenia
Adverse event was reported on Sep 13, 2010 by a Female patient taking Rituximab (View Usage) (Dosage: 780 Mg, Unk) was diagnosed with lymphocytic leukaemia and. Location: UNITED KINGDOM , weighting 121.3 lb, After Rituximab was administered, patient had the following side effects: febrile neutropenia. During the same period patient was treated with CYCLOPHOSPHAMIDE (195 Mg, Unk) (View Cyclophosphamide Review and Cyclophosphamide Label ), FLUDARABINE (19.5 Mg, Unk) (View Fludarabine Review and Fludarabine Label ), BISOPROLOL FUMARATE (Unk) (View Bisoprolol Fumarate Review and Bisoprolol Fumarate Label ), SULFATE FERREUX (Unk) (View Sulfate Ferreux Review and Sulfate Ferreux Label ), ATORVASTATIN (Unk) (View Atorvastatin Review and Atorvastatin Label ), OMEPRAZOLE (Unk) (View Omeprazole Review and Omeprazole Label ), ALDACTONE (Unk) (View Aldactone Review and Aldactone Label ). Patient was hospitalized.

7010610-3 | Anaphylactic Reaction, Hypoxia
on Sep 09, 2010 Male patient from UNITED KINGDOM , weighting 192.7 lb, was diagnosed with lymphoma (What is lymphoma?) and was treated with Rituximab (View Usage). Patient experienced the following unwanted or unexpected effects: anaphylactic reaction, hypoxia. Rituximab dosage: 375 Mg/m2, X1. During the same period patient was treated with CYCLOPHOSPHAMIDE (View Cyclophosphamide Review and Cyclophosphamide Label ), DOXORUBICIN HCL (View Doxorubicin Hcl Review and Doxorubicin Hcl Label ), VINCRISTINE (View Vincristine Review and Vincristine Label ), PREDNISOLONE (View Prednisolone Review and Prednisolone Label ), ACETAMINOPHEN (1 G, Unk) (View Acetaminophen Review and Acetaminophen Label ), HYDROCORTISONE (100 Mg, Unk) (View Hydrocortisone Review and Hydrocortisone Label ), PIRITON (10 Mg, Unk) (View Piriton Review and Piriton Label ). Patient was hospitalized.

7009871-6 | Anaemia, Arthralgia, Bone Pain, Dyspnoea, Groin Pain, Muscular Weakness, Musculoskeletal Pain, Oedema Peripheral
on Sep 09, 2010 Female patient from UNITED KINGDOM , weighting 260.1 lb, was diagnosed with rheumatoid arthritis (What is rheumatoid arthritis?), hypertension and was treated with Rituximab (View Usage). Patient had the following side effects: anaemia, arthralgia, bone pain, dyspnoea, groin pain, muscular weakness, musculoskeletal pain, oedema peripheral. Rituximab dosage: 100 Mg/10 Ml, Unk. During the same period patient was treated with OMEPRAZOLE (20 Mg, Unk) (View Omeprazole Review and Omeprazole Label ), DIOVAN (30 Mg, Unk) (View Diovan Review and Diovan Label ), FLUOXETINE (30 Mg, Unk) (View Fluoxetine Review and Fluoxetine Label ), METHOTREXATE (5 Mg, Unk) (View Methotrexate Review and Methotrexate Label ), RIVOTRIL (2 Mg, Unk) (View Rivotril Review and Rivotril Label ), NAPROXEN (500 Mg, Unk) (View Naproxen Review and Naproxen Label ).

7008622-9 | Confusional State, Gastric Perforation, Pneumonia, Splenic Vein Thrombosis
Patient was taking Rituximab (View Usage). After Rituximab was administered, patient had the following side effects: confusional state, gastric perforation, pneumonia (What is pneumonia?), splenic vein thrombosis on Sep 08, 2010 from UNITED KINGDOM Additional patient health information: Male patient , weighting 143.3 lb, was diagnosed with diffuse large b-cell lymphoma and. Rituximab dosage: 700 Mg, Q3w. During the same period patient was treated with CYCLOPHOSPHAMIDE (Unk) (View Cyclophosphamide Review and Cyclophosphamide Label ), DOXORUBICIN HCL (Unk) (View Doxorubicin Hcl Review and Doxorubicin Hcl Label ), VINCRISTINE (Unk) (View Vincristine Review and Vincristine Label ). Patient was hospitalized.

7007856-7 | Hepatitis B
Adverse event was reported on Sep 15, 2010 by a Female patient taking Rituximab (View Usage) (Dosage: ) was diagnosed with b-cell lymphoma and. Location: KOREA, REPUBLIC OF , weighting 110.2 lb, Patient experienced the following unwanted or unexpected effects: hepatitis b (What is hepatitis b?). During the same period patient was treated with FLUDARABINE (View Fludarabine Review and Fludarabine Label ), MITOXANTRONE HYDROCHLORIDE (View Mitoxantrone Hydrochloride Review and Mitoxantrone Hydrochloride Label ), URSODIOL (Not Provided) (View Ursodiol Review and Ursodiol Label ), DEXAMETHASONE (View Dexamethasone Review and Dexamethasone Label ).

7006500-2 | Jc Virus Infection, Progressive Multifocal Leukoencephalopathy
on Sep 09, 2010 Male patient from UNITED KINGDOM , 76 years of age, was diagnosed with chronic lymphocytic leukaemia and was treated with Rituximab (View Usage). Patient had the following side effects: jc virus infection, progressive multifocal leukoencephalopathy. Rituximab dosage: 375 Mg/m2, Unk. During the same period patient was treated with PREDNISOLONE (5 Mg, Unk) (View Prednisolone Review and Prednisolone Label ).

7006489-6 | Pulmonary Embolism
on Sep 07, 2010 Female patient from UNITED KINGDOM , weighting 229.3 lb, was diagnosed with rheumatoid arthritis (What is rheumatoid arthritis?) and was treated with Rituximab (View Usage). After Rituximab was administered, patient had the following side effects: pulmonary embolism (What is pulmonary embolism?). Rituximab dosage: 1000 Mg, Unk. During the same period patient was treated with METHOTREXATE (View Methotrexate Review and Methotrexate Label ). Patient was hospitalized.

7006386-6 | Pulmonary Embolism, Venous Thrombosis
Patient was taking Rituximab (View Usage). Patient experienced the following unwanted or unexpected effects: pulmonary embolism (What is pulmonary embolism?), venous thrombosis on Sep 08, 2010 from UNITED KINGDOM Additional patient health information: Male patient , weighting 198.4 lb, was diagnosed with non-hodgkin's lymphoma and. Rituximab dosage: 750 Mg, Unk. During the same period patient was treated with BENDAMUSTINE (180 Mg, Unk) (View Bendamustine Review and Bendamustine Label ), ATORVASTATIN CALCIUM (1 Df, Unk) (View Atorvastatin Calcium Review and Atorvastatin Calcium Label ), EZETIMIBE (1 Df, Unk) (View Ezetimibe Review and Ezetimibe Label ), OLMESARTAN MEDOXOMIL (1 Df, Unk) (View Olmesartan Medoxomil Review and Olmesartan Medoxomil Label ). Patient was hospitalized.

7003281-3 | Acute Vestibular Syndrome
Adverse event was reported on Sep 07, 2010 by a Female patient taking Rituximab (View Usage) (Dosage: 500 Mg/m2, Unk) was diagnosed with chronic lymphocytic leukaemia and. Location: GERMANY , 55 years of age, weighting 183.0 lb, Patient had the following side effects: acute vestibular syndrome. During the same period patient was treated with FLUDARABINE (48 Mg, Unk) (View Fludarabine Review and Fludarabine Label ), CYCLOPHOSPHAMIDE (478 Mg, Unk) (View Cyclophosphamide Review and Cyclophosphamide Label ), COTRIM (Unk) (View Cotrim Review and Cotrim Label ), PANTOPRAZOLE SODIUM (40 Mg, Qam) (View Pantoprazole Sodium Review and Pantoprazole Sodium Label ), ACICLOVIR (400 Mg, Unk) (View Aciclovir Review and Aciclovir Label ). Patient was hospitalized.

6994644-0 | Anaemia, Cytomegalovirus Duodenitis, Hepatic Steatosis, Hepatitis Cholestatic, Opportunistic Infection, Pleural Effusion, Protein-losing Gastroenteropathy, Rheumatoid Arthritis, Sepsis
on Sep 02, 2010 Female patient from UNITED KINGDOM , weighting 147.7 lb, was diagnosed with rheumatoid arthritis (What is rheumatoid arthritis?) and was treated with Rituximab (View Usage). After Rituximab was administered, patient had the following side effects: anaemia, cytomegalovirus duodenitis, hepatic steatosis, hepatitis cholestatic, opportunistic infection, pleural effusion, protein-losing gastroenteropathy, rheumatoid arthritis (What is rheumatoid arthritis?), sepsis (What is sepsis?). Rituximab dosage: 1000 Mg, Days 1+15. During the same period patient was treated with METHYLPREDNISOLONE (100 Mg, Days 1+15) (View Methylprednisolone Review and Methylprednisolone Label ), PREDNISONE (Unk) (View Prednisone Review and Prednisone Label ), METHOTREXATE (15 Mg, 1/week) (View Methotrexate Review and Methotrexate Label ), FOLIC ACID (Unk) (View Folic Acid Review and Folic Acid Label ), CALCIMAGON D3 (Unk) (View Calcimagon-d3 Review and Calcimagon-d3 Label ), ENALAPRIL (Unk) (View Enalapril Review and Enalapril Label ), RALOXIFENE HCL (Unk) (View Raloxifene Hcl Review and Raloxifene Hcl Label ), MICROPIRIN (Unk) (View Micropirin Review and Micropirin Label ). Patient was hospitalized and became disabled.

6994564-1 | Traumatic Lung Injury
on Sep 06, 2010 Male patient from UNITED KINGDOM , weighting 155.4 lb, was diagnosed with diffuse large b-cell lymphoma and was treated with Rituximab (View Usage). Patient experienced the following unwanted or unexpected effects: traumatic lung injury. Rituximab dosage: 700 Mg, Unk. During the same period patient was treated with CYCLOPHOSPHAMIDE (Unk) (View Cyclophosphamide Review and Cyclophosphamide Label ), DOXORUBICIN HCL (Unk) (View Doxorubicin Hcl Review and Doxorubicin Hcl Label ), VINCRISTINE (Unk) (View Vincristine Review and Vincristine Label ). Patient was hospitalized.

6994397-6 | Asthenia, Candidiasis, Dehydration, Dysphagia
Patient was taking Rituximab (View Usage). Patient had the following side effects: asthenia, candidiasis, dehydration, dysphagia on Sep 03, 2010 from UNITED KINGDOM Additional patient health information: Female patient , weighting 155.4 lb, was diagnosed with diffuse large b-cell lymphoma and. Rituximab dosage: 660 Mg, Unk. During the same period patient was treated with CYCLOPHOSPHAMIDE (1330 Mg, Unk) (View Cyclophosphamide Review and Cyclophosphamide Label ), DOXORUBICIN HCL (88 Mg, Unk) (View Doxorubicin Hcl Review and Doxorubicin Hcl Label ), VINCRISTINE (2 Mg, Unk) (View Vincristine Review and Vincristine Label ), PREDNISONE (100 Mg, Unk) (View Prednisone Review and Prednisone Label ), ACYCLOVIR SODIUM (400 Mg, Qid) (View Acyclovir Sodium Review and Acyclovir Sodium Label ), DECORTIN (50 Mg, Bid) (View Decortin Review and Decortin Label ), NEULASTA (6 Mg, Unk) (View Neulasta Review and Neulasta Label ), KEPINOL FORTE (Unk Unk, 2/week) (View Kepinol Forte Review and Kepinol Forte Label ). Patient was hospitalized.